Editorial: “US stem cell research leaves the Bush era behind“
Something for everyone (Image: Digital Vision/Getty)
AFTER years of hype, controversy and disappointment, stem cell treatments may finally be poised to reach masses of patients. The world’s first successful implant of a synthetic windpipe raises the prospect of implanting patients with a host of “off-the-peg” synthetic structures coated with their own stem cells. And in South Korea last week, regulators became the first in the world to approve for sale to hospitals a stem cell therapy for people who have had heart attacks.
Further from the clinic, but still with…
